Literature DB >> 8221659

Resistance to fluorodeoxyuridine-induced DNA damage and cytotoxicity correlates with an elevation of deoxyuridine triphosphatase activity and failure to accumulate deoxyuridine triphosphate.

C E Canman1, T S Lawrence, D S Shewach, H Y Tang, J Maybaum.   

Abstract

Deoxyuridine triphosphate (dUTP) misincorporation and uracil misrepair have long been implicated in fluoropyrimidine-induced DNA damage; however, the enzymatic activities responsible for these lesions have not been previously identified as critical determinants of overall sensitivity to the antitumor effects of these agents. The purpose of this study was to determine whether differences in uracil misincorporation/misrepair could account for the difference in sensitivity to fluorodeoxyuridine (FdUrd)-induced cytotoxicity and DNA damage in 2 human colorectal tumor cell lines having identical sensitivities to FdUrd-induced thymidylate synthase inhibition. Compared to HT29 cells, SW620 cells were resistant to both cytotoxicity and induction of DNA double-strand breaks, as assessed by pulse field gel electrophoresis. Alkaline elution experiments demonstrated that this resistance coincided with delayed induction of DNA single-strand breaks on parental DNA and, to a lesser extent, on nascent DNA. Following treatment with FdUrd for 24 h, HT29 cells accumulated 904 +/- 273 pmol deoxyuridine triphosphate (dUTP)/10(7) cells, whereas SW620 cells accumulated 20 +/- 7 pmol dUTP. Consistent with this difference in extent of dUTP accumulation was the observation that deoxyuridine triphosphatase levels in SW620 cellular extracts were 4.4-fold higher than in HT29 extracts. The ability to accumulate dUTP, intracellular deoxyuridine triphosphatase activity, and extent of DNA damage appear to be important determinants for predicting the response to FdUrd treatment in these cell lines.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8221659

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

1.  5-Fluorouracil-based chemotherapy for colorectal cancer and MTHFR/MTRR genotypes.

Authors:  Barbara Pardini; Rajiv Kumar; Alessio Naccarati; Jan Novotny; Rashmi B Prasad; Asta Forsti; Kari Hemminki; Pavel Vodicka; Justo Lorenzo Bermejo
Journal:  Br J Clin Pharmacol       Date:  2011-07       Impact factor: 4.335

Review 2.  Uracil in DNA: consequences for carcinogenesis and chemotherapy.

Authors:  Sondra H Berger; Douglas L Pittman; Michael D Wyatt
Journal:  Biochem Pharmacol       Date:  2008-07-01       Impact factor: 5.858

3.  Effect of the thymidylate synthase inhibitors on dUTP and TTP pool levels and the activities of DNA repair glycosylases on uracil and 5-fluorouracil in DNA.

Authors:  Breeana C Grogan; Jared B Parker; Amy F Guminski; James T Stivers
Journal:  Biochemistry       Date:  2011-01-11       Impact factor: 3.162

4.  Dependence of fluorodeoxyuridine-induced cytotoxicity and megabase DNA fragment formation on S phase progression in HT29 cells.

Authors:  H Y Tang; K L Weber; T S Lawrence; A K Merchant; J Maybaum
Journal:  Cancer Chemother Pharmacol       Date:  1996       Impact factor: 3.333

5.  Description of a novel eukaryotic deoxyuridine 5'-triphosphate nucleotidohydrolase in Leishmania major.

Authors:  A Camacho; R Arrebola; J Peña-Diaz; L M Ruiz-Pérez; D González-Pacanowska
Journal:  Biochem J       Date:  1997-07-15       Impact factor: 3.857

Review 6.  5-Fluorouracil: forty-plus and still ticking. A review of its preclinical and clinical development.

Authors:  J L Grem
Journal:  Invest New Drugs       Date:  2000-11       Impact factor: 3.850

7.  Replication in vitro and in vivo of an equine infectious anemia virus mutant deficient in dUTPase activity.

Authors:  D L Lichtenstein; K E Rushlow; R F Cook; M L Raabe; C J Swardson; G J Kociba; C J Issel; R C Montelaro
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

8.  Predictive and prognostic markers in colorectal cancer.

Authors:  Peter M Wilson; Robert D Ladner; Heinz-Josef Lenz
Journal:  Gastrointest Cancer Res       Date:  2007-11

Review 9.  Participation of DNA repair in the response to 5-fluorouracil.

Authors:  M D Wyatt; D M Wilson
Journal:  Cell Mol Life Sci       Date:  2009-03       Impact factor: 9.261

Review 10.  Standing the test of time: targeting thymidylate biosynthesis in cancer therapy.

Authors:  Peter M Wilson; Peter V Danenberg; Patrick G Johnston; Heinz-Josef Lenz; Robert D Ladner
Journal:  Nat Rev Clin Oncol       Date:  2014-04-15       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.